Experts recommendations on RSV and meningitis vaccines will go to ex-prosecutor now at CDC
- On Wednesday, the ACIP recommended wider use of vaccines for RSV, meningitis, and chikungunya.
- The Advisory Committee on Immunization Practices makes vaccine recommendations to the CDC director.
- GSK's combination vaccine protects against five types of meningococcal bacteria; one type links to past outbreaks.
- For an older chikungunya vaccine, six older adults had heart or brain symptoms after the shot.
- Recent CDC leadership changes, including Susan Monarez awaiting Senate confirmation, may complicate the next steps.
84 Articles
84 Articles
How does the government track vaccine safety?
The Journalist’s Resource’s explainer on childhood vaccine safety includes a primer on how the government tracks vaccine safety data. As changes are proposed to federal vaccine policy, this guide can help understand the implications of these changes. How vaccine side effects are tracked in the U.S. Before vaccines arrive on the market, they go through […] The post How does the government track vaccine safety? appeared first on Shorenstein Center.

Vaccine Panel Urges More Protection Against RSV, Meningitis and Chikungunya
Key Takeaways
Experts' Vaccine Recommendations Will Go to Ex-Prosecutor Now at CDC
(MedPage Today) -- A federal panel of medical experts on Wednesday recommended an expansion of respiratory syncytial virus (RSV) vaccinations for adults and a new combination shot as another option to protect teens against meningitis. The 15-member...

Experts make new recommendations on RSV and meningitis vaccines, but it's unclear what happens next
A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis.
Coverage Details
Bias Distribution
- 61% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage